Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Effects of Various ATG Doses on Rejection Rate and Immune Recovery in Haploidentical T and B Cell Depleted Stem Cell Transplantation

Peter J. Lang, MD, Friedhelm Schuster, Bernd Gruhn, Roland Meisel, MD, Patrick Schlegel, MD, Anne-Marie Lang, Chihab Klose, Wolfgang Schwinger, MD, Tobias F. Feuchtinger, Prof. Dr. MD, Heiko-Manuel Teltschik, Holger Martinius, Michael Schumm, DVM, Rupert Handgretinger, MD

Blood (2017) 130 (Supplement 1): 3250.

https://doi.org/10.1182/blood.V130.Suppl_1.3250.3250

Published: 2017

Journal Articles

Improved Immune Recovery after Transplantation of TCRαβ/CD19 Depleted Allografts from Haploidentical Donors in Pediatric Patients

Peter Lang, MD, Tobias Feuchtinger, MD, Heiko-Manuel Teltschik, MD, Wolfgang Schwinger, MD, Patrick Schlegel, MD, Michael Schumm, DVM, Anne-Marie Lang, Barbara Lang, MD, Carl Philipp Schwarze, MD, Martin Ebinger, MD, Christian E. Urban, MD, Rupert Handgretinger

Blood (2014) 124 (21): 852.

https://doi.org/10.1182/blood.V124.21.852.852

Published: 2014

Journal Articles

Alternative Donor Stem Cell Transplantation In Aplastic Anemias and Refractory Cytopenias Is Save and Feasible With T- and B-Cell Depleted Haploidentical Grafts

Tobias Feuchtinger, MD, Heiko-Manuel Teltschik, MD, Matthias Pfeiffer, Ingo Mueller, Andre Schrauder, MD, Rupert Handgretinger, Peter Lang, MD

Blood (2013) 122 (21): 4573.

https://doi.org/10.1182/blood.V122.21.4573.4573

Published: 2013

Journal Articles

Transplantation Of TcRαβ/CD19 Depleted Stem Cells From Haploidentical Donors In Children: Current Results

Peter Lang, MD, Tobias Feuchtinger, MD, Heiko-Manuel Teltschik, MD, Michael Schumm, DVM, Patrick Schlegel, MD, Matthias Pfeiffer, MD, Martin Ebinger, MD, Carl-Philipp Schwarze, MD, Rupert Handgretinger

Blood (2013) 122 (21): 692.

https://doi.org/10.1182/blood.V122.21.692.692

Published: 2013

Journal Articles

Use of a Fc-Optimized CD19 Antibody for Treatment of MRD in Pediatric Patients with B-Lineage Acute Lymphoblastic Leukemia

Peter Lang, MD, Heiko-Manuel Teltschik, MD, Patrick Schlegel, MD, Ursula Seidel, Ludger Grosse-Hovest, PhD, Steffen Aulwurm, PhD, Martin Hofmann, Rouwen Teltschik, Kai Witte, MD, Hans-Georg Rammensee, Prof., Gundram Jung, MD, Rupert Handgretinger, MD

Blood (2012) 120 (21): 581.

https://doi.org/10.1182/blood.V120.21.581.581

Published: 2012

Journal Articles

A New Dosing Scheme of ATG-F Prevents Rejection and Maintains Immune Recovery in Haploidentical T and B Cell Depleted Stem Cell Transplantation

Peter Lang, MD, Tobias F. Feuchtinger, MD, Patrick Schlegel, MD, Heiko-Manuel Teltschik, MD, Roland Meisel, MD, Friedhelm R. Schuster, MD, Bernd Gruhn, MD, Wolfgang Schwinger, MD, Christian E. Urban, MD, Holger Martinius, Ulrike Pflückhahn, Rouwen Teltschik, Christina Kyzirakos, Michael Schumm, DVM, Rupert Handgretinger, MD

Blood (2012) 120 (21): 4154.

https://doi.org/10.1182/blood.V120.21.4154.4154

Published: 2012

Journal Articles

Flow Cytometry Based Chimerism Analysis Can Predict Graft Rejection in Pediatric Patients Receiving HLA Mismatched Stem Cell Transplantation

Heiko-Manuel Teltschik, MD, Hanna Kreil, Patrick Schlegel, MD, Tobias F. Feuchtinger, MD, Michael Schumm, DVM, Rupert Handgretinger, MD, Peter Lang, MD

Blood (2012) 120 (21): 4156.

https://doi.org/10.1182/blood.V120.21.4156.4156

Published: 2012

Journal Articles

NK Cell Activity Influences Long Term Outcome of Pediatric Leucemias After T Cell Depleted Stem Cell Transplantation,

Peter Lang, MD, Matthias Pfeiffer, MD, Heiko-Manuel Teltschik, MD, Paul G. Schlegel, MD, Tobias F. Feuchtinger, MD, Thomas Klingebiel, MD, James F. Beck, MD, Rupert Handgretinger, MD

Blood (2011) 118 (21): 4141.

https://doi.org/10.1182/blood.V118.21.4141.4141

Published: 2011

Journal Articles

Transplantation of TcRαβ/CD19 Depleted Stem Cells From Haploidentical Donors: Robust Engraftment and Rapid Immune Reconstitution In Children with High Risk Leukemia

Rupert Handgretinger, MD, Peter Lang, MD, Tobias F. Feuchtinger, MD, Michael Schumm, DVM, Heiko-Manuel Teltschik, MD, Ansgar S Schulz, MD, PhD, Volker Huppert, PhD, Lorenzo Moretta, MD, Alesandro Moretta, MD, Maria Ester Bernardo, MD, Maurizio Caniglia, MD, Alice Bertaina, MD, Francesco Zinno, MD, Franco Locatelli, MD

Blood (2011) 118 (21): 1005.

https://doi.org/10.1182/blood.V118.21.1005.1005

Published: 2011

Journal Articles

Use of IL15 Stimulated, CD3/19 Depleted Transplants From Haploidentical Donors In Pediatric Malignancies

Peter Lang, Matthias Pfeiffer, Heiko-Manuel Teltschik, Tobias F. Feuchtinger, MD, Martin Ebinger, Ingo Mueller, Michael Schumm, Rupert Handgretinger, MD, PhD

Blood (2010) 116 (21): 3548.

https://doi.org/10.1182/blood.V116.21.3548.3548

Published: 2010

Journal Articles

Improved T Cell Recovery After Transplantation of CD3/CD19 depleted Haploidentical Stem Cell Grafts in Pediatric Patients.

Heiko-Manuel Teltschik, Tobias Feuchtinger, Matthias Pfeiffer, Michael Schumm, Ingo Mueller, Rupert Handgretinger, Peter J. Lang, MD

Blood (2009) 114 (22): 4652.

https://doi.org/10.1182/blood.V114.22.4652.4652

Published: 2009

Journal Articles

Long Term Survival and Relapse Rate After Transplantation of Highly T and B Cell Depleted Stem Cells From Alternative Donors in Pediatric Patients with Acute Lymphatic Leukemia.

Peter J. Lang, MD, Ingo Mueller, Heiko-Manuel Teltschik, Michael Schumm, Matthias Pfeiffer, Tobias Feuchtinger, Johann Greil, Peter Bader, Thomas Klingebiel, MD, Rupert Handgretinger, MD

Blood (2009) 114 (22): 4333.

https://doi.org/10.1182/blood.V114.22.4333.4333

Published: 2009

Journal Articles

Co-Transfusion of Donor NK Cells in Haploidentical Stem Cell Transplantation

Peter J. Lang, MD, Matthias Pfeiffer, MD, Heiko-Manuel Teltschik, MD, Ingo Mueller, MD, Tobias Feuchtinger, MD, Michael Schumm, MD, Rupert Handgretinger, MD

Blood (2008) 112 (11): 2907.

https://doi.org/10.1182/blood.V112.11.2907.2907

Published: 2008

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Effects of Various ATG Doses on Rejection Rate and Immune Recovery in Haploidentical T and B Cell Depleted Stem Cell Transplantation

Improved Immune Recovery after Transplantation of TCRαβ/CD19 Depleted Allografts from Haploidentical Donors in Pediatric Patients

Alternative Donor Stem Cell Transplantation In Aplastic Anemias and Refractory Cytopenias Is Save and Feasible With T- and B-Cell Depleted Haploidentical Grafts

Transplantation Of TcRαβ/CD19 Depleted Stem Cells From Haploidentical Donors In Children: Current Results

Use of a Fc-Optimized CD19 Antibody for Treatment of MRD in Pediatric Patients with B-Lineage Acute Lymphoblastic Leukemia

A New Dosing Scheme of ATG-F Prevents Rejection and Maintains Immune Recovery in Haploidentical T and B Cell Depleted Stem Cell Transplantation

Flow Cytometry Based Chimerism Analysis Can Predict Graft Rejection in Pediatric Patients Receiving HLA Mismatched Stem Cell Transplantation

NK Cell Activity Influences Long Term Outcome of Pediatric Leucemias After T Cell Depleted Stem Cell Transplantation,

Transplantation of TcRαβ/CD19 Depleted Stem Cells From Haploidentical Donors: Robust Engraftment and Rapid Immune Reconstitution In Children with High Risk Leukemia

Use of IL15 Stimulated, CD3/19 Depleted Transplants From Haploidentical Donors In Pediatric Malignancies

Improved T Cell Recovery After Transplantation of CD3/CD19 depleted Haploidentical Stem Cell Grafts in Pediatric Patients.

Long Term Survival and Relapse Rate After Transplantation of Highly T and B Cell Depleted Stem Cells From Alternative Donors in Pediatric Patients with Acute Lymphatic Leukemia.

Co-Transfusion of Donor NK Cells in Haploidentical Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only